DocGo (NASDAQ:DCGO) Stock Keeps Buy Rating at Needham & Company LLC

DocGo (NASDAQ:DCGO)‘s stock had its “buy” rating reissued by equities research analysts at Needham & Company LLC in a research report issued on Wednesday, Benzinga reports.

A number of other equities research analysts also recently weighed in on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of DocGo in a report on Monday, September 14th. Canaccord Genuity Group restated a “hold” rating and issued a $1.00 target price on shares of DocGo in a research note on Tuesday, August 18th. Three research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $2.38.

DocGo Stock Up 0.4%

Shares of DCGO traded up $0.00 during trading hours on Wednesday, reaching $0.37. The company’s stock had a trading volume of 151,806 shares, compared to its average volume of 875,437. The company has a 50 day moving average of $0.47 and a two-hundred day moving average of $0.56. DocGo has a 1-year low of $0.31 and a 1-year high of $1.65. The firm has a market cap of $36.70 million, a price-to-earnings ratio of -0.19 and a beta of 0.97.

DocGo (NASDAQ:DCGO) last issued its earnings results on Monday, August 17th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.06). The firm had revenue of $73.42 million during the quarter, compared to the consensus estimate of $75.35 million. DocGo had a negative return on equity of 40.42% and a negative net margin of 65.29%. As a group, analysts forecast that DocGo will post -0.22 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC grew its position in DocGo by 167.1% in the 1st quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock worth $950,000 after purchasing an additional 944,826 shares during the period. S Squared Technology LLC bought a new stake in shares of DocGo during the second quarter valued at approximately $1,060,725. BlackRock Inc. purchased a new position in shares of DocGo in the second quarter valued at $750,000. Empowered Funds LLC purchased a new position in shares of DocGo in the second quarter valued at $79,000. Finally, Ieq Capital LLC purchased a new position in shares of DocGo in the second quarter valued at $126,000. Institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc (NASDAQ: DCGO) is a healthcare services and technology company that delivers medical care and transportation outside traditional clinical settings. Its platform combines mobile clinical services, technology-enabled care coordination and non-emergency medical transportation to help healthcare providers, government agencies, insurers and employers serve patients in their homes and communities.

The company’s services include ambulance and non-emergency medical transportation, mobile primary and urgent care, remote patient monitoring, diagnostic testing, vaccination programs and community-based healthcare.